Skip to main content
Premium Trial:

Request an Annual Quote

Calibre Scientific Acquires Sequencing Sample Prep Reagent Firm BrightBox Quantitation

NEW YORK – Calibre Scientific said on Wednesday that it has acquired San Mateo, California-based sequencing sample prep reagent manufacturer BrightBox Quantitation.

Financial and other terms of the transaction were not disclosed.

BrightBox Quantitation produces and distributes an assay kit for the rapid quantification of next-generation sequencing libraries. According to BrightBox’s website and LinkedIn page, the company produces one type of product and has no more than 10 employees.

Los Angeles-based Calibre said BrightBox will join its EdgeBio division, and the acquisition will enhance the company’s presence in the DNA sequencing sector.

“We're excited to add BrightBox Quantitation kits to our portfolio: They will make NGS workflows faster, easier, and more cost-effective for our customers, allowing them to increase throughput capacity and deliver consistent, high-quality results,” EdgeBio’s general manager Avesta Ebrahimi said in a statement.

Early this month, Calibre acquired AmpliTech, a French life science reagent and instrument distributor. Also, in late 2020, Calibre acquired Ontario-based life science product distributor Canadian Life Science.

Calibre did not respond to a request for additional information before deadline.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.